Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector

In the injector market, the transition from in-hospital injection to home injection is accelerating due to changes in the market environment, awareness, and behavior, and expectations for the use of Motorized Digital Injectors are increasing year by year. Our company has developed the OSTABALOⓇ Inje...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug Delivery System 2023/11/25, Vol.38(5), pp.445-449
Hauptverfasser: Kitahara, Kaori, Mori, Masakazu, Fujimura, Katsumasa, Aoki, Toru, Seto, Kohei, Asakura, Toshinari
Format: Artikel
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 449
container_issue 5
container_start_page 445
container_title Drug Delivery System
container_volume 38
creator Kitahara, Kaori
Mori, Masakazu
Fujimura, Katsumasa
Aoki, Toru
Seto, Kohei
Asakura, Toshinari
description In the injector market, the transition from in-hospital injection to home injection is accelerating due to changes in the market environment, awareness, and behavior, and expectations for the use of Motorized Digital Injectors are increasing year by year. Our company has developed the OSTABALOⓇ Injector, which is a dedicated injector for the osteoporosis treatment drug OSTABALOⓇ subcutaneous injection cartridge 1.5mg, which is manufactured by TEIJIN PHARMA LIMITED. This report describes our efforts in product development, the features of Motorized Digital Injector, the differences from non-Motorized Digital Injector, and considers the possibilities of Motorized Digital Injectors.
doi_str_mv 10.2745/dds.38.445
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3054699398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3054699398</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2235-daec4742d549ff428e5f7fe64cae9474d8dadd862c2b010fae15a1ec4ebad5a63</originalsourceid><addsrcrecordid>eNo90EtOwzAUBVALgUQpTFhBJGZIKf4mzoBBoXwqFXXQMrbc-LkkSuNipwjYAAtgh6wEo5aOLL977CddhM4JHtCciytjwoDJAefiAPWIlCSlOaOHqIcLwlKBcXaMTkKoMeYxJD00G8EbNG69grZLnE2ms_nwZjiZ_nx_JeO2hrJzPtGtSeB9HS-6q1wbEhuHTy5G1SeYZFQtq043e3-KjqxuApztzj56vr-b3z6mk-nD-HY4SUtKmUiNhpLnnBrBC2s5lSBsbiHjpYYiBkYabYzMaEkXmGCrgQhN4htYaCN0xvroYvvv2rvXDYRO1W7j27hSMSx4VhSskFFdblXpXQgerFr7aqX9hyJY_ZWmYmmKSRVLi_h6i-vQ6SXsqfZdVTbwT8XO7-fli_YKWvYLUHJ3iw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3054699398</pqid></control><display><type>article</type><title>Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>J-STAGE (Japan Science &amp; Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><creator>Kitahara, Kaori ; Mori, Masakazu ; Fujimura, Katsumasa ; Aoki, Toru ; Seto, Kohei ; Asakura, Toshinari</creator><creatorcontrib>Kitahara, Kaori ; Mori, Masakazu ; Fujimura, Katsumasa ; Aoki, Toru ; Seto, Kohei ; Asakura, Toshinari</creatorcontrib><description>In the injector market, the transition from in-hospital injection to home injection is accelerating due to changes in the market environment, awareness, and behavior, and expectations for the use of Motorized Digital Injectors are increasing year by year. Our company has developed the OSTABALOⓇ Injector, which is a dedicated injector for the osteoporosis treatment drug OSTABALOⓇ subcutaneous injection cartridge 1.5mg, which is manufactured by TEIJIN PHARMA LIMITED. This report describes our efforts in product development, the features of Motorized Digital Injector, the differences from non-Motorized Digital Injector, and considers the possibilities of Motorized Digital Injectors.</description><identifier>ISSN: 0913-5006</identifier><identifier>EISSN: 1881-2732</identifier><identifier>DOI: 10.2745/dds.38.445</identifier><language>eng ; jpn</language><publisher>Kawasaki: THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM</publisher><subject>Digital Injector ; Injection ; Injectors ; Motorized ; Motorized Digital Injector ; OSTABALO ; Osteoporosis ; Pharmaceuticals ; PHC ; Product development ; TEIJIN</subject><ispartof>Drug Delivery System, 2023/11/25, Vol.38(5), pp.445-449</ispartof><rights>2023 The Japan Society of Drug Delivery System</rights><rights>Copyright Japan Science and Technology Agency 2023</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,1877,27905,27906</link.rule.ids></links><search><creatorcontrib>Kitahara, Kaori</creatorcontrib><creatorcontrib>Mori, Masakazu</creatorcontrib><creatorcontrib>Fujimura, Katsumasa</creatorcontrib><creatorcontrib>Aoki, Toru</creatorcontrib><creatorcontrib>Seto, Kohei</creatorcontrib><creatorcontrib>Asakura, Toshinari</creatorcontrib><title>Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector</title><title>Drug Delivery System</title><addtitle>DDS</addtitle><description>In the injector market, the transition from in-hospital injection to home injection is accelerating due to changes in the market environment, awareness, and behavior, and expectations for the use of Motorized Digital Injectors are increasing year by year. Our company has developed the OSTABALOⓇ Injector, which is a dedicated injector for the osteoporosis treatment drug OSTABALOⓇ subcutaneous injection cartridge 1.5mg, which is manufactured by TEIJIN PHARMA LIMITED. This report describes our efforts in product development, the features of Motorized Digital Injector, the differences from non-Motorized Digital Injector, and considers the possibilities of Motorized Digital Injectors.</description><subject>Digital Injector</subject><subject>Injection</subject><subject>Injectors</subject><subject>Motorized</subject><subject>Motorized Digital Injector</subject><subject>OSTABALO</subject><subject>Osteoporosis</subject><subject>Pharmaceuticals</subject><subject>PHC</subject><subject>Product development</subject><subject>TEIJIN</subject><issn>0913-5006</issn><issn>1881-2732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo90EtOwzAUBVALgUQpTFhBJGZIKf4mzoBBoXwqFXXQMrbc-LkkSuNipwjYAAtgh6wEo5aOLL977CddhM4JHtCciytjwoDJAefiAPWIlCSlOaOHqIcLwlKBcXaMTkKoMeYxJD00G8EbNG69grZLnE2ms_nwZjiZ_nx_JeO2hrJzPtGtSeB9HS-6q1wbEhuHTy5G1SeYZFQtq043e3-KjqxuApztzj56vr-b3z6mk-nD-HY4SUtKmUiNhpLnnBrBC2s5lSBsbiHjpYYiBkYabYzMaEkXmGCrgQhN4htYaCN0xvroYvvv2rvXDYRO1W7j27hSMSx4VhSskFFdblXpXQgerFr7aqX9hyJY_ZWmYmmKSRVLi_h6i-vQ6SXsqfZdVTbwT8XO7-fli_YKWvYLUHJ3iw</recordid><startdate>20231125</startdate><enddate>20231125</enddate><creator>Kitahara, Kaori</creator><creator>Mori, Masakazu</creator><creator>Fujimura, Katsumasa</creator><creator>Aoki, Toru</creator><creator>Seto, Kohei</creator><creator>Asakura, Toshinari</creator><general>THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM</general><general>Japan Science and Technology Agency</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20231125</creationdate><title>Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector</title><author>Kitahara, Kaori ; Mori, Masakazu ; Fujimura, Katsumasa ; Aoki, Toru ; Seto, Kohei ; Asakura, Toshinari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2235-daec4742d549ff428e5f7fe64cae9474d8dadd862c2b010fae15a1ec4ebad5a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; jpn</language><creationdate>2023</creationdate><topic>Digital Injector</topic><topic>Injection</topic><topic>Injectors</topic><topic>Motorized</topic><topic>Motorized Digital Injector</topic><topic>OSTABALO</topic><topic>Osteoporosis</topic><topic>Pharmaceuticals</topic><topic>PHC</topic><topic>Product development</topic><topic>TEIJIN</topic><toplevel>online_resources</toplevel><creatorcontrib>Kitahara, Kaori</creatorcontrib><creatorcontrib>Mori, Masakazu</creatorcontrib><creatorcontrib>Fujimura, Katsumasa</creatorcontrib><creatorcontrib>Aoki, Toru</creatorcontrib><creatorcontrib>Seto, Kohei</creatorcontrib><creatorcontrib>Asakura, Toshinari</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Drug Delivery System</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kitahara, Kaori</au><au>Mori, Masakazu</au><au>Fujimura, Katsumasa</au><au>Aoki, Toru</au><au>Seto, Kohei</au><au>Asakura, Toshinari</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector</atitle><jtitle>Drug Delivery System</jtitle><addtitle>DDS</addtitle><date>2023-11-25</date><risdate>2023</risdate><volume>38</volume><issue>5</issue><spage>445</spage><epage>449</epage><pages>445-449</pages><issn>0913-5006</issn><eissn>1881-2732</eissn><abstract>In the injector market, the transition from in-hospital injection to home injection is accelerating due to changes in the market environment, awareness, and behavior, and expectations for the use of Motorized Digital Injectors are increasing year by year. Our company has developed the OSTABALOⓇ Injector, which is a dedicated injector for the osteoporosis treatment drug OSTABALOⓇ subcutaneous injection cartridge 1.5mg, which is manufactured by TEIJIN PHARMA LIMITED. This report describes our efforts in product development, the features of Motorized Digital Injector, the differences from non-Motorized Digital Injector, and considers the possibilities of Motorized Digital Injectors.</abstract><cop>Kawasaki</cop><pub>THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM</pub><doi>10.2745/dds.38.445</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0913-5006
ispartof Drug Delivery System, 2023/11/25, Vol.38(5), pp.445-449
issn 0913-5006
1881-2732
language eng ; jpn
recordid cdi_proquest_journals_3054699398
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese
subjects Digital Injector
Injection
Injectors
Motorized
Motorized Digital Injector
OSTABALO
Osteoporosis
Pharmaceuticals
PHC
Product development
TEIJIN
title Development of OSTABALOⓇ Injector and expectations for Motorized Digital Injector
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T07%3A21%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20OSTABALO%E2%93%87%20Injector%20and%20expectations%20for%20Motorized%20Digital%20Injector&rft.jtitle=Drug%20Delivery%20System&rft.au=Kitahara,%20Kaori&rft.date=2023-11-25&rft.volume=38&rft.issue=5&rft.spage=445&rft.epage=449&rft.pages=445-449&rft.issn=0913-5006&rft.eissn=1881-2732&rft_id=info:doi/10.2745/dds.38.445&rft_dat=%3Cproquest_cross%3E3054699398%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3054699398&rft_id=info:pmid/&rfr_iscdi=true